Gastroenterology January 2026 ly Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC

This research investigates how tracking the concentration and processing speed of infliximab can determine the success of emergency treatment for acute severe ulcerative colitis. By analyzing blood and stool samples, the study discovered that low drug levels and rapid clearance shortly after the first dose are strong predictors of treatment failure and the future need for surgery. The findings suggest that patients who eliminate the medication quickly benefit significantly from intensified dosing, which can overcome high clearance rates to prevent a colectomy. Ultimately, the text highlights that early therapeutic drug monitoring provides a vital window for clinicians to personalize treatment and improve survival rates for the colon in high-risk patients.